Enzyme-Linked Immunosorbent Assay Market

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples?serum, plasma, cell culture supernatants and cell lysates?indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.

Enzyme-Linked Immunosorbent Assay Market contains market size and forecasts of Enzyme-Linked Immunosorbent Assay (ELISA) in Global, including the following market information:

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Enzyme-Linked Immunosorbent Assay (ELISA) market was valued at 184.2 million in 2021 and is projected to reach US$ 233.5 million by 2028, at a CAGR of 3.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Sandwich ELISA Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Enzyme-Linked Immunosorbent Assay (ELISA) include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences and BioM?rieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Enzyme-Linked Immunosorbent Assay (ELISA) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Segment Percentages, by Type, 2021 (%)

Sandwich ELISA

Indirect ELISA

Competitive ELISA

Others

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Segment Percentages, by Application, 2021 (%)

Immunology

Inflammation

Infectious Diseases

Cancer

Protein Quantitation

Others

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Enzyme-Linked Immunosorbent Assay (ELISA) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Enzyme-Linked Immunosorbent Assay (ELISA) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

R&D Systems

Thermo Fisher Scientific

Ortho Clinical Diagnostics

BD Biosciences

ZEUS Scientific

Bio-Rad Laboratories

ALPCO

Enzo Life Sciences

BioM?rieux

EMD Millipore

BioLegend

LOEWE Biochemica

Mercodia

Cusabio

Shanghai Kehua Bio-engineering